Phase I Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females
Phase of Trial: Phase I
Latest Information Update: 05 May 2015
Price : $35 *
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors CONRAD
- 05 May 2015 Last checked against ClinicalTrials.gov record.
- 30 Apr 2015 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Sep 2014 New trial record